Because of increased use of synthetic neuromuscular blocking drugs, there has been an increase in the number of reported cases of hypersensitivity reactions, caused partly by immunological mechanisms (reaginic) [1] and in the majority of cases by non-immunological factors (release of histamine, complement activation etc.) [2, 3] .
Pancuronium is well tolerated, but cases of undesirable secondary reactions have been reported [2] [3] [4] .
We report here a case of anaphylactic shock caused by pancuronium bromide in which a type I immunological mechanism (IgE mediated) was implicated.
CASE REPORT
A 33-yr-old male anaesthetist with no family or personal history of allergy, had twice undergone surgery under general anaesthesia. An appendicectomy was performed at age 11 yr and the removal of a salivary gland at age 28 yr (table I) . The drugs administered during the first operation remain unknown, but during the second operation the patient received thiopentone, suxamethonium, tubocurarine, halothane, neostigmine and atropine, without any complications.
On the present admission the patient was scheduled to undergo cholecystectomy. Premedication comprised diazepam and atropine and anaesthesia was induced with fentanyl-droperidol and thiopentone followed by pancuronium i.v. Immediately after the administration of these drugs, the patient developed cardiovascular collapse and diffuse erythema, with probable cardiac arrest. Cardiac massage was performed immediately and resuscitation instituted with colloids i.v. (gelatins) and methylprednisolone, atropine, metaraminol, adrenaline, bicarbonate, dopamine and mannitol were administered. The patient responded to this treatment and made a good recovery. Surgery was postponed.
Fifteen days after the episode, the case was brought to our attention and we performed the following tests: skin tests, passive transfer according to Prausnitz and Kustner [5] (the patient's serum was screened for hepatitis antigen and antibody, syphilis and AIDS by the use of HTLV-III antibody), lymphocyte in vitro transformation test and total IgE radioimmunoassay (Prist-Pharmacia).
Skin tests were performed with intradermal (i.d.) injections of appropriate concentrations of atropine, diazepam, tubocurarine, thiopentone, enflurane, fazadinium, pancuronium and suxamethonium (table II) . Negative results were obtained for all the drugs used, with the exception of pancuronium bromide. 
An injection of pancuronium 0.05 ml highly diluted to 10~1 2 was followed by the appearance of a 1-cm diameter weal surrounded by a 4-cm diameter erythematous halo. A similar i.d. injection to 10 healthy control subjects was negative; this test was performed to exclude the possibility that the positive reaction was caused by histamine release [3] .
Passive transfer according to Prausnitz and Kustner [5] was carried out. This test is used to confirm the positive nature of a skin test by transferring the reaction to a volunteer. The aim is to induce the specific IgE (if present in the examined serum) to fix on the surface of the skin mast cell. The further administration of the allergen in the same site causes an antigenantibody reaction, resulting in a weal and flare. The patient's serum (fresh and heated to 56 °C for 3 h) was injected i.d. (0.1 ml) in several areas of the volar surface of the forearm in two members of the patient's family. After 4 h and 48 h, the two family volunteers were injected i.d. with pancuronium 0.1 ml (1:10000), suxamethonium, tubocurarine and with normal saline in the same sites as the preceding inoculations of serum. The 4-h interval was used to reveal skin-sensitizing IgG ("short term sensitizing antibodies"); the 48-h interval was used to reveal IgE. Readings after 4 h were negative, whereas after 48 h a weal and flare reaction was evident only in the site, pretreated with unheated serum, to which pancuronium was subsequently injected.
The in vitro lymphocyte transformation test was carried out using a radioisotopic technique using thymidine 2-C 14 (Radiochemical Centre Amersham) [6] . A stimulation index of 3 was considered significant. The stimulation index is calculated by dividing the number of counts per minute from cultures with the antigen, by number of counts per minute from the non-stimulated control cultures. In this test the following antigen solutions were used: pancuronium and suxamethonium (0.02 ml of solutions diluted by 10" 3 , 10" 4 and 10~5). These non-lymphotoxic doses had been determined previously by culturing the lymphocytes in the presence of 0.05 ml ml" 1 of rehydrated BACTO-Phytohaemagglutinin M Difco (PHA) culture with various doses of the drugs for 4 days. Control cultures were prepared also with no antigen, or with the addition of 0.2 ml of a solution of PHA. Significant increase in lymphocyte proliferation was observed in cultures with pancuronium (stimulation index = 5.7). No significant increase in thymidine incorporation was observed in the cultures with suxamethonium.
Subsequently, the patient underwent uneventful cholecystectomy with a drug regimen as shown in table I.
DISCUSSION
The results obtained from our patient confirm an immunological pathogenesis mediated by IgE (passive transfer was prevented by heating the serum for 3 h at 56 °C: IgE are antibodies which denature at high temperatures).
Minimal concentrations of pancuronium (10~1 2 ) produced positive skin reactions in the patient, with no responses in the 10 control subjects: this excludes histamine release as a mechanism. On the other hand, the Prausnitz and Kiistner test was positive, after 48 h, only with the non-heated serum, demonstrating the presence of long term sensitizing antibodies, involved in type I immunoreactions.
The positive lymphocyte transformation test demonstrated the presence of memory T cells capable of recognizing the antigen and of proliferating. This indicates that the patient's immune system had already been in contact with the antigen and had induced an immunological response. With radioimmunoassay for total IgE (Prist-Pharmacia), a result within normal limits (64 ku. litre" 1 ) was obtained for our patient. This is compatible with drug allergy [7] .
It is not clear how the patient was sensitized to pancuronium. The drugs used in his first anaesthesia remain unknown and is possible that pancuronium was used. Alternatively, it is possible that sensitization occurred transcutaneously (or even by inhalation) as the patient worked as an anaesthetist. Cross-sensitivity with other neuromuscular blocking drugs may be excluded [8] as the testing was negative for both tubocurarine and suxamethonium. Furthermore, the patient underwent a subsequent general anaesthesia with suxamethonium, without incurring problems. For this reason, the quaternary ammonium group cannot be considered responsible for the drug allergy [9] .
